Related Experiment Video

Updated: Jun 11, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Split-course hypofractionated palliative radiotherapy for patients with head and neck squamous cell carcinoma - a

R A Pearson, R H Bannister-Young, D Ivison

    Clinical Oncology (Royal College of Radiologists (Great Britain))
    |June 30, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Stereotactic Radiosurgery for Gynecologic Cancer
    10:35

    Stereotactic Radiosurgery for Gynecologic Cancer

    Published on: April 17, 2012

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
    08:34

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

    Published on: February 6, 2019

    Related Experiment Videos

    Last Updated: Jun 11, 2026

    Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
    06:11

    Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

    Published on: April 20, 2018

    Stereotactic Radiosurgery for Gynecologic Cancer
    10:35

    Stereotactic Radiosurgery for Gynecologic Cancer

    Published on: April 17, 2012

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
    08:34

    Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

    Published on: February 6, 2019

    Related Concept Videos

    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

    Articles linked to this work by shared authors, journal, and citation graph.

    Verification imaging in prostate MR-only radiotherapy: Are fiducial markers necessary?

    Radiography (London, England : 1995)·2024

    The first patients treated with MR-CBCT soft-tissue matching in a MR-only prostate radiotherapy pathway.

    Radiography (London, England : 1995)·2023

    A comprehensive atlas of Aggrecan, Versican, Neurocan and Phosphacan expression across time in wildtype retina and in retinal degeneration.

    Scientific reports·2022

    Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2018

    Measurement of the bone endocortical region using clinical CT.

    Medical image analysis·2017

    Chemotherapy: United Kingdom National Multidisciplinary Guidelines.

    The Journal of laryngology and otology·2016

    HYPOCON: A Randomised Proof of Concept Clinical Trial of Biphasic Fractionation Schedules to Overcome Hypoxia in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Treated with Curative Intent Primary Chemo-radiotherapy.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    Real-world Experience with Sotorasib in KRAS G12C-Mutated Advanced Non-small Cell Lung Cancer: Clinical Outcomes and Tolerability in the UK.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    Acute Myocardial Infarction in Head and Neck Cancer Patients and Survivors: A Population-Based Cohort Study of Patient, Disease, and Treatment Factors.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    Patient-reported Outcomes after Standard and Dose-escalated Prostate Stereotactic Body Radiotherapy.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    A Multicentre Retrospective Cohort Study of Hypofractionated Radiotherapy in Head and Neck Cancer.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    UK Photon Radiotherapy Practice for Oligodendroglioma -Data From the Analysis of Proton vs Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health Trial (ISRCTN:1339049) Radiotherapy Quality Assurance (RTQA) Programme.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2026

    The effects of combined aerobic and resistance exercise on metabolic blood biomarkers and quality of life in patients with breast cancer: a systematic review meta-analysis.

    Frontiers in oncology·2026

    New advances in the treatment of chronic rhinosinusitis with nasal polyps from pathophysiology to biologic targeted therapy.

    Frontiers in allergy·2026

    Case Report: Can this 90-year-old patient with cT4N3M0 NSCLC have concurrent chemoradiation for cure? Learning from a representive case.

    Frontiers in oncology·2026

    Conjunctival reactive cutaneous capillary endothelial proliferation induced by camrelizumab in an esophageal cancer patient: a case report and literature review.

    Frontiers in oncology·2026

    Oxygen-Gradient-Responsive Photosensitizing Gadolinium Phthalocyaninate for Self-Adaptive Type II/I Photodynamic Therapy Toward Heterogeneous Tumor Suppression.

    Small (Weinheim an der Bergstrasse, Germany)·2026

    An Immunogenic Cell Death-Enhanced Self-Assembled Nanoparticle-Composite Hydrogel for Postoperative Local Immunotherapy of Melanoma.

    Omics : a journal of integrative biology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us